News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Weisman Harlan F
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/15/2023 |
4
| Weisman Harlan F (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
| Bought 600,000 shares
@ $0.25, valued at
$150k
|
|
03/13/2023 |
4
| Weisman Harlan F (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
| Bought 150,000 shares
@ $0.8789, valued at
$131.8k
|
|
12/19/2022 |
4
| Weisman Harlan F (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
| Bought 50,000 shares
@ $1.06, valued at
$53k
|
|
12/06/2022 |
4
| Weisman Harlan F (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
| Granted 1,792,450 options to buy
@ $1.19, valued at
$2.1M
|
|
05/20/2022 |
4
| Weisman Harlan F (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
| Bought 2,500 shares
@ $5.12, valued at
$12.8k
Bought 4,615 shares
@ $5.5, valued at
$25.4k
|
|
05/17/2022 |
4
| Weisman Harlan F (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
| Bought 2,500 shares
@ $4.74, valued at
$11.9k
|
|
08/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/03/2019 |
4
| Weisman Harlan F (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
| Granted 3,623 options to buy
@ $5, valued at
$18.1k
|
|
10/29/2019 |
4
| Weisman Harlan F (Director) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
| Bought 5,000 shares
@ $5, valued at
$25k
Granted 43,794 options to buy
@ $5, valued at
$219k
|
|
10/24/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/21/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/15/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/20/2012 |
3
| Weisman Harlan F (Director) has filed a Form 3 on CORONADO BIOSCIENCES INC |
|
|